cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Deciphera Pharmaceuticals Inc
3 own
8 watching
Current Price
$12.94
$0.33
(2.62%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,050.91M
52-Week High
52-Week High
22.76000
52-Week Low
52-Week Low
9.90000
Average Volume
Average Volume
0.54M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,050.91M
icon52-Week High22.76000
icon52-Week Low9.90000
iconAverage Volume0.54M
iconDividend Yield--
iconP/E Ratio--
What does the Deciphera Pharmaceuticals Inc do?
Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of various cancer therapies. The company's lead drug candidate is DCC-2618, which is in Phase III trial for the treatment of gastrointestinal stromal tumors; and that is in Phase I trial for treating advanced systemic mastocytosis, gliomas, melanoma, NSCLC/germ cell/penile, and soft tissue sarcomas. It is also developing immunokinase inhibitors comprising DCC-3014 that is in Phase I trial for treatment of solid tumors and hematologic malignancies; and Rebastinib, which is in Phase 1b/II trial to treat solid tumors, as well as to investigate in combination with chemotherapy for the treatment of multiple solid tumors. The company was founded in 2003 and is headquartered in Waltham, Massachusetts.
Read More
How much money does Deciphera Pharmaceuticals Inc make?
News & Events about Deciphera Pharmaceuticals Inc.
Benzinga
7 months ago
read more...
Business Wire
9 months ago
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in fireside chats at the...
Market News Video
9 months ago
In trading on Thursday, shares of Deciphera Pharmaceuticals Inc (DCPH) crossed below their 200 day moving average of 15.37, changing hands as low as 14.88 per share. Deciphera Pharmaceuticals Inc shares are currently trading off about 2.3% on the day...
Ticker Report
10 months ago
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH Get Rating) major shareholder Brightstar Associates Llc bought 1,666,666 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Tuesday, January 24th. The shares were acquired at an average cost of $18.00 per share, for a ...
Frequently Asked Questions
Frequently Asked Questions
What is Deciphera Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Deciphera Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Deciphera Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Deciphera Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Deciphera Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Deciphera Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Deciphera Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Deciphera Pharmaceuticals Inc?
plus_minus_icon
What percentage is Deciphera Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Deciphera Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$12.94
$0.33
(2.62%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
INHIBRX INC
INHIBRX INC
$22.39
$1.62 (7.80 %)
89bio Inc
89bio Inc
$8.40
$0.36 (4.48 %)
Avid Bioservices Inc
Avid Bioservices Inc
$5.00
$-0.09 (-1.77 %)
Kiniksa Pharmaceuticals Ltd
Kiniksa Pharmaceuticals Ltd
$16.81
$0.64 (3.96 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
INHIBRX INC
INHIBRX INC
$22.39
$1.62 (7.80 %)
89bio Inc
89bio Inc
$8.40
$0.36 (4.48 %)
Avid Bioservices Inc
Avid Bioservices Inc
$5.00
$-0.09 (-1.77 %)
Kiniksa Pharmaceuticals Ltd
Kiniksa Pharmaceuticals Ltd
$16.81
$0.64 (3.96 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00